Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Indivior (INDV) Share News

IN BRIEF: Indivior Chair Graham Hetherington to retire at year-end

4th Oct 2024 11:33

Indivior PLC - Richmond, Virginia-based specialty pharmaceuticals company - On Thursday, the company announced that Chair Graham Hetherington intends to retire from his role and the board at the end of the year for personal reasons. He has served as chair for four years and been a member of the board for five years. Indivior has started the search to identify a new chair. Read More

Indivior reports "disappointing" results for study with Aelis Farma

4th Sep 2024 14:07

(Alliance News) - Indivior PLC on Wednesday said the primary and secondary endpoints were not met in a trial of AEF0117 in patients with cannabis use disorder. Read More

LONDON BROKER RATINGS: UBS raises Hargreaves Lansdown; DB cuts JD

12th Aug 2024 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET OPEN: Earnings woe sends European stocks lower

25th Jul 2024 08:54

(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York. Read More

LONDON BRIEFING: Astra ups outlook; Unilever and Lloyds back view

25th Jul 2024 07:49

(Alliance News) - London's FTSE 100 is called to open lower on Thursday, with a sell-off of US technology shares filtering through to trade in Europe and in Asia. Read More

UK earnings, trading statements calendar - next 7 days

19th Jul 2024 15:32

UK earnings, trading statements calendar - next 7 days

18th Jul 2024 16:07

LONDON BROKER RATINGS: Barclays raises Kerry, cuts Hunting, Wood Group

10th Jul 2024 10:08

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

Competition for Sublocade "clearly" hits Indivior as warns on profit

9th Jul 2024 11:10

(Alliance News) - Indivior PLC shares tumbled on Tuesday as it warned on profit amid weaker sales of a key opioid treatment, as well as a charge relating to a schizophrenia drug. Read More

TOP NEWS: Indivior lowers 2024 outlook and calls time on Perseris

9th Jul 2024 09:48

(Alliance News) - Shares in Indivior PLC plunged on Tuesday after it flagged lower than expected sales of its opioid treatment, Sublocade, and said it expects to take a charge relating to schizophrenia drug, Perseris. Read More

Indivior celebrates transfer of primary listing to Nasdaq in US

27th Jun 2024 10:04

(Alliance News) - Indivior PLC on Thursday confirmed that it has successfully transferred its primary listing to the Nasdaq Stock Market in the US. Read More

IN BRIEF: Indivior reconfirms 2024 outlook amid NY-listing decision

23rd May 2024 12:29

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Reconfirms financial guidance for 2024 ahead of analyst 'teach-in' event in New York. Indivior also on Thursday is asking shareholders to approve moving its primary listing to New York from London. Read More

UK shareholder meetings calendar - next 7 days

16th May 2024 15:46

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

3rd May 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

UK shareholder meetings calendar - next 7 days

2nd May 2024 13:48

Indivior shares down despite profit boost on planned shift to New York

25th Apr 2024 09:23

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York. Read More

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

27th Mar 2024 11:56

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation. Read More

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

18th Mar 2024 14:28

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares. Read More

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

12th Mar 2024 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

8th Mar 2024 20:04

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600. Read More

FTSE 100 Latest

Value8,275.66

Change0.00